Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2393
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey ; volume:17 ; number:1 ; day:13 ; month:9 ; year:2017 ; pages:1-6 ; date:12.2017
BMC pregnancy and childbirth ; 17, Heft 1 (13.9.2017), 1-6, 12.2017
- Schlagwort
-
Schwangerschaftsstörung
- Urheber
-
Chollat, Clément
- Beteiligte Personen und Organisationen
-
Le Doussal, Lise
de la Villéon, Gaëlle
Provost, Delphine
Marret, Stéphane
SpringerLink (Online service)
- DOI
-
10.1186/s12884-017-1489-z
- URN
-
urn:nbn:de:1111-201711148835
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chollat, Clément
- Le Doussal, Lise
- de la Villéon, Gaëlle
- Provost, Delphine
- Marret, Stéphane
- SpringerLink (Online service)
Ähnliche Objekte (12)
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
Magnesium sulfate for fetal neuroprotection in preterm pregnancy: a meta-analysis of randomized controlled trials
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
Antenatal management of fetal neurosurgical diseases
Magnesium sulphate within multimodal analgesia, pre-emptive, or preventive analgesia
Magnesium treatment for neuroprotection in ischemic diseases of the brain
Antenatal assessment of fetal outcome in pregnant diabetics
Glucocorticoids influence versican and chondroitin sulphate proteoglycan levels in the fetal sheep lung
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
Magnesium sulfate for fetal neuroprotection in preterm pregnancy: a meta-analysis of randomized controlled trials
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
Antenatal management of fetal neurosurgical diseases
Magnesium sulphate within multimodal analgesia, pre-emptive, or preventive analgesia
Magnesium treatment for neuroprotection in ischemic diseases of the brain
Antenatal assessment of fetal outcome in pregnant diabetics
Glucocorticoids influence versican and chondroitin sulphate proteoglycan levels in the fetal sheep lung
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
Magnesium sulfate for fetal neuroprotection in preterm pregnancy: a meta-analysis of randomized controlled trials
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
Antenatal management of fetal neurosurgical diseases
Magnesium sulphate within multimodal analgesia, pre-emptive, or preventive analgesia
Magnesium treatment for neuroprotection in ischemic diseases of the brain
Antenatal assessment of fetal outcome in pregnant diabetics